Fortress Biotech Inc
NASDAQ:FBIO
Balance Sheet
Balance Sheet Decomposition
Fortress Biotech Inc
Fortress Biotech Inc
Balance Sheet
Fortress Biotech Inc
| Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||
| Cash & Cash Equivalents |
2
|
15
|
23
|
40
|
100
|
50
|
98
|
88
|
95
|
66
|
137
|
233
|
306
|
178
|
81
|
57
|
|
| Cash Equivalents |
2
|
15
|
23
|
40
|
100
|
50
|
98
|
88
|
95
|
66
|
137
|
233
|
306
|
178
|
81
|
57
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
20
|
0
|
2
|
36
|
18
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
9
|
8
|
8
|
14
|
25
|
24
|
28
|
15
|
10
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
8
|
6
|
14
|
24
|
23
|
28
|
15
|
10
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
1
|
2
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
10
|
14
|
10
|
14
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
1
|
1
|
2
|
10
|
44
|
20
|
4
|
7
|
7
|
10
|
11
|
8
|
|
| Total Current Assets |
2
|
15
|
23
|
41
|
100
|
71
|
100
|
110
|
183
|
111
|
156
|
266
|
347
|
230
|
117
|
90
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
7
|
12
|
34
|
32
|
34
|
33
|
23
|
17
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
7
|
12
|
34
|
32
|
34
|
33
|
23
|
17
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
5
|
7
|
9
|
12
|
9
|
12
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
17
|
1
|
1
|
7
|
15
|
13
|
27
|
20
|
32
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
19
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
4
|
3
|
1
|
1
|
0
|
11
|
18
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
15
|
15
|
16
|
53
|
16
|
18
|
3
|
3
|
4
|
7
|
5
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
19
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
2
N/A
|
15
+776%
|
23
+57%
|
41
+75%
|
101
+145%
|
89
-11%
|
119
+33%
|
171
+44%
|
246
+44%
|
141
-43%
|
226
+61%
|
333
+47%
|
397
+19%
|
294
-26%
|
168
-43%
|
144
-14%
|
|
| Liabilities | |||||||||||||||||
| Accounts Payable |
1
|
1
|
1
|
1
|
1
|
0
|
2
|
24
|
28
|
34
|
23
|
29
|
67
|
77
|
53
|
48
|
|
| Accrued Liabilities |
2
|
1
|
3
|
2
|
5
|
4
|
8
|
12
|
1
|
1
|
16
|
19
|
25
|
23
|
23
|
20
|
|
| Short-Term Debt |
9
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
2
|
6
|
0
|
0
|
2
|
13
|
19
|
7
|
5
|
5
|
7
|
3
|
1
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
18
|
30
|
1
|
0
|
0
|
4
|
21
|
6
|
3
|
|
| Total Current Liabilities |
11
|
2
|
4
|
5
|
11
|
4
|
11
|
57
|
71
|
56
|
46
|
52
|
101
|
128
|
85
|
71
|
|
| Long-Term Debt |
1
|
0
|
1
|
12
|
7
|
14
|
23
|
26
|
49
|
60
|
82
|
60
|
47
|
93
|
61
|
58
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
27
|
45
|
68
|
18
|
46
|
97
|
117
|
8
|
21
|
24
|
|
| Other Liabilities |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
5
|
5
|
5
|
26
|
25
|
23
|
23
|
20
|
17
|
|
| Total Liabilities |
12
N/A
|
2
-86%
|
4
+163%
|
19
+352%
|
19
+2%
|
19
-3%
|
62
+229%
|
132
+114%
|
193
+46%
|
139
-28%
|
200
+44%
|
233
+16%
|
288
+23%
|
253
-12%
|
145
-43%
|
121
-16%
|
|
| Equity | |||||||||||||||||
| Common Stock |
0
|
29
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
10
|
20
|
57
|
84
|
121
|
142
|
190
|
245
|
312
|
396
|
436
|
483
|
548
|
634
|
695
|
741
|
|
| Additional Paid In Capital |
0
|
4
|
76
|
106
|
203
|
212
|
247
|
284
|
364
|
397
|
462
|
583
|
656
|
676
|
717
|
764
|
|
| Total Equity |
10
N/A
|
13
N/A
|
19
+43%
|
22
+15%
|
81
+270%
|
71
-13%
|
57
-19%
|
39
-32%
|
53
+37%
|
2
-96%
|
26
+1 279%
|
100
+283%
|
109
+8%
|
42
-62%
|
23
-46%
|
23
+1%
|
|
| Total Liabilities & Equity |
2
N/A
|
15
+776%
|
23
+57%
|
41
+75%
|
101
+145%
|
89
-11%
|
119
+33%
|
171
+44%
|
246
+44%
|
141
-43%
|
226
+61%
|
333
+47%
|
397
+19%
|
294
-26%
|
168
-43%
|
144
-14%
|
|
| Shares Outstanding | |||||||||||||||||
| Common Shares Outstanding |
1
|
1
|
1
|
2
|
3
|
3
|
3
|
3
|
3
|
4
|
5
|
6
|
7
|
7
|
15
|
28
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
3
|
3
|
3
|
3
|
|